Effect of Aronia Berry Consumption on Inflammatory Parameters

The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters. It will be conducted at a research hospital in Istanbul, involving 50 participants aged 50-80 diagnosed with COPD. Participants will be randomly assigned to two groups: the aronia group (AG, n=25) and the placebo group (PG, n=25). The AG will receive 30 g of freeze-dried aronia powder daily, while the PG will receive 30 g of placebo powder, both for a duration of 8 weeks. Baseline demographic data will be collected through face-to-face interviews, while biochemical, respiratory, anthropometric, and body composition parameters will be assessed both before and after the intervention. Dietary intake records will also be collected and analyzed.

NCT Number	NCT06702696
Lead Sponsor	Amasya University
Conditions	COPD (Chronic Obstructive Pulmonary Disease)
Enrollment	50 participants
Start Date	2024-11-15
Primary Completion	2025-09-15 (estimated)
Study Completion	2025-11-15 (estimated)
Updated on ClinicalTrials.gov	2025-10-01